Rare antibodies identified in FNAIT-affected pregnancy
Researchers studied a rare case of prolonged fetal and neonatal alloimmune thrombocytopenia (FNAIT) caused by three different antibody types.
Researchers studied a rare case of prolonged fetal and neonatal alloimmune thrombocytopenia (FNAIT) caused by three different antibody types.
The increase in immunoglobulin administration for a wide range of conditions, including FNAIT, underscores the need to refine care guidelines.
Platelet transfusions are often required to treat FNAIT, however recent evidence suggests that they could produce serious complications.
A newborn with thrombocytopenia, of which FNAIT is a differential diagnosis, was eventually diagnosed with Wiskott-Aldrich syndrome.
A recent case report highlighted how a well-planned approach can help prevent FNAIT in pregnancies at higher risk.
Infants have distinct hematological features compared to adults, which has implications for the treatment of diseases such as FNAIT.
Critically ill children who receive a platelet transfusion before central line placement have an elevated risk of bleeding, a study found.
Neuroprotection bundles, including proper positioning, pain management and respiratory support, can help prevent IVH.
COVID-19 infection at any stage of pregnancy did not lead to worse health outcomes for mothers or infants in a recent study in China.
A case of a newborn with thrombocytopenia illustrated the value of considering all possible FNAIT differential diagnoses, including HLH.